Related Experiment Video

Updated: May 22, 2026

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model
06:25

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model

Published on: July 12, 2024

Takotsubo cardiomyopathy: its possible impact during adult donor care

David J Powner1, Hanh Truong

  • 1Vivian L. Smith Department of Neurosurgery, University of Texas Health Sciences Center at Houston Medical School, USA. djpowner@gmail.com

Progress in Transplantation (Aliso Viejo, Calif.)
|May 3, 2012
PubMed

Insights

Takotsubo cardiomyopathy and brain death share cardiac similarities due to catecholamine release. Treatments for Takotsubo cardiomyopathy may inform donor care strategies.

Area of Science:

  • Cardiology
  • Neurology
  • Transplantation

Background:

  • Takotsubo cardiomyopathy involves extreme catecholamine release, leading to cardiac dysfunction.
  • Similar cardiac changes are observed after brain death in animal and human studies.
  • Myocardial beta-receptor overstimulation can impair cardiac contractility.

Purpose of the Study:

  • To explore the parallels between Takotsubo cardiomyopathy and brain death-induced cardiac alterations.
  • To identify potential therapeutic strategies for donor care based on Takotsubo cardiomyopathy treatments.

Main Methods:

  • Comparative analysis of histopathological and clinical findings.
  • Review of existing literature on Takotsubo cardiomyopathy and brain death cardiac effects.

Main Results:

  • Identified shared features in cardiac response to extreme catecholamine surges.
  • Highlighted the role of beta-receptor stimulation in myocardial dysfunction.

Conclusions:

  • Takotsubo cardiomyopathy and brain death present comparable cardiac challenges.
  • Extracorporeal support and non-beta-receptor-dependent medications are potential avenues for donor management.
  • Preemptive beta-blockade or calcium channel blockade may be relevant for donor care.

More Related Videos

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Pre-clinical Model of Cardiac Donation after Circulatory Death06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...